Mercè Roget

455 total citations
8 papers, 134 citations indexed

About

Mercè Roget is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Mercè Roget has authored 8 papers receiving a total of 134 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hepatology, 7 papers in Epidemiology and 5 papers in Infectious Diseases. Recurrent topics in Mercè Roget's work include Hepatitis C virus research (7 papers), Hepatitis B Virus Studies (6 papers) and HIV/AIDS drug development and treatment (4 papers). Mercè Roget is often cited by papers focused on Hepatitis C virus research (7 papers), Hepatitis B Virus Studies (6 papers) and HIV/AIDS drug development and treatment (4 papers). Mercè Roget collaborates with scholars based in Spain, Australia and United States. Mercè Roget's co-authors include A Marco, Juan Ignacio Esteban, Joan A. Caylà, Núria Teixidó, Rafael Guerrero, Mercedes Vergara, Mireia Miquel, Bonaventura Clotet, Lluís Force and Cristina Tural and has published in prestigious journals such as Journal of Hepatology, Frontiers in Oncology and European Journal of Gastroenterology & Hepatology.

In The Last Decade

Mercè Roget

7 papers receiving 131 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mercè Roget Spain 6 121 113 42 6 4 8 134
Nail Özgüneş Türkiye 5 55 0.5× 79 0.7× 31 0.7× 8 1.3× 6 1.5× 8 99
Helen Tuite Ireland 6 64 0.5× 88 0.8× 54 1.3× 12 2.0× 5 1.3× 15 118
Akaki Abutidze Georgia 7 112 0.9× 147 1.3× 53 1.3× 26 4.3× 4 1.0× 28 176
K.E. Sherman United States 8 163 1.3× 136 1.2× 57 1.4× 10 1.7× 12 3.0× 19 196
Samir Dervisevic United Kingdom 7 84 0.7× 95 0.8× 117 2.8× 11 1.8× 3 0.8× 11 194
H. Lafeuille France 6 69 0.6× 84 0.7× 20 0.5× 11 1.8× 4 1.0× 10 117
Anaïs Corma‐Gómez Spain 6 62 0.5× 69 0.6× 41 1.0× 3 0.5× 4 1.0× 26 113
Hayette Rougier France 7 169 1.4× 190 1.7× 50 1.2× 10 1.7× 1 0.3× 23 208
P. Trimoulet France 5 148 1.2× 103 0.9× 62 1.5× 2 0.3× 2 0.5× 7 156
Mercy Karoney Kenya 3 137 1.1× 142 1.3× 15 0.4× 5 0.8× 3 0.8× 7 159

Countries citing papers authored by Mercè Roget

Since Specialization
Citations

This map shows the geographic impact of Mercè Roget's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mercè Roget with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mercè Roget more than expected).

Fields of papers citing papers by Mercè Roget

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mercè Roget. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mercè Roget. The network helps show where Mercè Roget may publish in the future.

Co-authorship network of co-authors of Mercè Roget

This figure shows the co-authorship network connecting the top 25 collaborators of Mercè Roget. A scholar is included among the top collaborators of Mercè Roget based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mercè Roget. Mercè Roget is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Sòria, Anna, Mariona Calvo, Meritxell Casas, et al.. (2022). Survival and adverse events of elderly patients treated with sorafenib for hepatocellular carcinoma. Frontiers in Oncology. 12. 829483–829483.
2.
Miquel, Mireia, Albert Pardo, Meritxell Casas, et al.. (2020). Current trends in access to treatment for hepatitis B in immigrants vs non-immigrants. Gastroenterology report. 8(5). 362–366. 5 indexed citations
3.
Marco, A, Mercè Roget, M. Forné, et al.. (2018). Comparison of effectiveness and discontinuation of interferon‐free therapy for hepatitis C in prison inmates and noninmates. Journal of Viral Hepatitis. 25(11). 1280–1286. 13 indexed citations
4.
Sánchez‐Delgado, Jordi, Mercedes Vergara, Eva Criado, et al.. (2018). Analysis of survival and prognostic factors in treatment of hepatocellular carcinoma in Spanish patients with drug-eluting bead transarterial chemoembolization. European Journal of Gastroenterology & Hepatology. 30(12). 1453–1460. 1 indexed citations
5.
Marco, A, Juan Ignacio Esteban, Mercè Roget, et al.. (2013). Hepatitis C virus reinfection among prisoners with sustained virological response after treatment for chronic hepatitis C. Journal of Hepatology. 59(1). 45–51. 58 indexed citations
6.
Moreno, Eva, Antònia Andreu, Mercedes Vergara, et al.. (2008). Role of host and bacterial virulence factors in Escherichia coli spontaneous bacterial peritonitis. European Journal of Gastroenterology & Hepatology. 20(9). 924–929. 17 indexed citations
7.
Fuster, Daniel, Ramón Planas, Juan González, et al.. (2006). Results of a Study of Prolonging Treatment with Pegylated Interferon-α2A plus Ribavirin in HIV/HCV-Coinfected Patients with No Early Virological Response. Antiviral Therapy. 11(4). 473–482. 23 indexed citations
8.
Fuster, Daniel, Guadalupe Gómez Melis, Ricard Solà, et al.. (2005). Baseline Factors associated with Haematological Toxicity that Leads to a Dosage Reduction of Pegylated Interferon-α2a and Ribavirin in HIV- and HCV-Coinfected Patients on HCV Antiviral Therapy. Antiviral Therapy. 10(7). 841–847. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nail Özgüneş Breakdown of academic impact, for papers by Helen Tuite Breakdown of academic impact, for papers by Akaki Abutidze Breakdown of academic impact, for papers by K.E. Sherman Breakdown of academic impact, for papers by Samir Dervisevic Breakdown of academic impact, for papers by H. Lafeuille Breakdown of academic impact, for papers by Anaïs Corma‐Gómez Breakdown of academic impact, for papers by Hayette Rougier Breakdown of academic impact, for papers by P. Trimoulet Breakdown of academic impact, for papers by Mercy Karoney
Rankless by CCL
2026